According to the research report titled ‘Global Concussion Market Size study, by Diagnosis & Treatment (Diagnosis, Treatment), by End-User (Hospitals and Clinics, Diagnostic Centers, Payers) and Regional Forecasts 2020-2027’, available with Market Study Report, global concussion market was valued at USD 6.8 billion in 2019, and is anticipated to grow at an annual rate of over 3.6% during 2020-2027, accruing USD 9 billion by the end of the stipulated timeframe.
 

As per the research report, rising number of sports injuries as well as road accidents in developing countries, coupled with growing incidences of mildly traumatic brain injuries are the key factors responsible for global concussion market growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2956055/
 

According to the International Journal of Environmental Research and Public Health, about 2,44,937 road accidents were registered in China in 2018, that led to 63,194 fatalities and 258,532 injuries. Such trends in the other nations are anticipated to elevate the prevalence of brain injuries, thereby boosting the demand for diagnosis and treatment of concussions.
 

For those unversed, a concussion is defined as a brain injury caused by violent shaking of the head and body or a bump/blow to the head. Temporary cognitive symptoms may consist memory loss, headache, nausea, and problems with balance, concentration, and coordination.
 

Elaborating on the factors hindering global concussion market expansion, lack of awareness about treatment of brain injuries, as well as strict regulatory framework are projected to impede business development in the ensuing years.
 

Based on type, global concussion market is split into diagnosis and treatment. By end-users, the industry is categorized into diagnostic centers, clinics & hospitals, and payers.
 

On the regional front, key contributors to the overall industry value are North America, Europe, Asia Pacific, and Latin America.
 

Industry experts cite that North America accounts for majority of global concussion market share owing to rising awareness and government initiatives for concussion prevention. Parallelly, Asia Pacific is projected to be the fastest growing region during the forecast period due to spike in cases of sports injuries and road accidents, along with ongoing advancements in healthcare infrastructure in developing nations such as India, and China.
 

Major players in global concussion market sphere are Sanofi S.A., Teva Pharmaceutical Industries Ltd., Novartis International AG, Integra LifeSciences Corporation, Mylan N.V., Medtronic Plc, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., Lupin Ltd., and Cadila Healthcare Ltd.